The Clinical Significance of Incidental WhiteMatterLesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)
Project Number5U19NS120384-02
Contact PI/Project LeaderDECARLI, CHARLES Other PIs
Awardee OrganizationUNIVERSITY OF CALIFORNIA AT DAVIS
Description
Abstract Text
PROJECT SUMMARY – Overall
Initially identified on MRI in 1986 as “…incidental lesions of uncertain clinical significance associated with
cerebrovascular risk factors”, whitematter hyperintensities (WMH) are a common consequence of the aging
process exacerbated by vascular risk factors. WMH also influence cognition and evolution of WMH are
associated with declines in both memory and executive function while extensive WMH predict incident MCI,
stroke and dementia. WMH and infarction also have a negative impact on cognition independent or in addition
to concurrent amyloid status. The impact of WMH is consistent with evidence that clinical dementia is a
multifactorial processes. The impact of WMH on dementia is also consistent with the fact that dementia risk
scales emphasize the role of vascular risk in dementia prediction.
As the US population becomes increasingly older and more diverse, the number of Americans with dementia is
expected to rise substantially, particularly for those with concomitant vascular disease. Importantly, the impact
of vascular disease on dementia risk may be exacerbated in African Americans and Hispanics, who are at
greater risk for vascular disease and for whom vascular disease may play a larger role in clinical dementia.
As awareness of dementia increases, it is becoming common to see individuals presenting for clinical
assessment with minor cognitive complaints. Neuroimaging studies frequently identify “incidental” WMH,
usually ascribed to “microvascular disease” by radiologists, raising patient concerns about their brain health
and future risk for dementia. To date, however, we are not aware of any studies that have
comprehensively examined the impact of individual and combined MRI measures of whitematter injury
on cognitive performance among a diverse, non-demented, stroke free population with cognitive
complaints over an extended period of observation. To address this important gap in scientific knowledge,
we propose the following aims:
Aim 1. To identify the extent and characteristics of whitematter injury that influence cognitive and health
outcomes
Aim 2. Evaluate Mechanisms of progression of WhiteMatter (WM) Injury on Cognition and Health Outcomes
Aim. 3. Based on findings from Aims 1 and 2, build and validate a predictive risk model with the ultimate goal of
increasing the understanding of precision medical management and planning needed by patients with whitematterlesions, both for need for care as was inclusion criteria for future therapeutic studies.
Impact: Given recent data showing that the impact of vascular risk factors on dementia can be modified by
effective treatment in later life potentially lessening population burden of dementia, developing strategies that
recognize and precisely treat the contribution of VCID to dementia burden is a public health imperative.
Public Health Relevance Statement
PROJECT NARRATIVE – Overall
As the US population becomes increasingly older and more diverse, the number of Americans with dementia is
expected to rise substantially, particularly among those with concomitant vascular disease. The Clinical
significance of INciDEntal whitematterlEsions on MRI in a Diverse population with cognitive complaints
(INDEED) proposes to comprehensively examine the impact of individual and combined MRI measures of
whitematter injury on cognitive performance among a diverse, non-demented, stroke free population with
cognitive complaints over an extended period of observation.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
047120084
UEI
TX2DAGQPENZ5
Project Start Date
30-September-2020
Project End Date
31-August-2027
Budget Start Date
01-September-2021
Budget End Date
31-August-2023
Project Funding Information for 2021
Total Funding
$13,212,214
Direct Costs
$8,943,935
Indirect Costs
$4,268,279
Year
Funding IC
FY Total Cost by IC
2021
National Institute on Aging
$13,212,214
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U19NS120384-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U19NS120384-02
Patents
No Patents information available for 5U19NS120384-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U19NS120384-02
Clinical Studies
No Clinical Studies information available for 5U19NS120384-02
News and More
Related News Releases
No news release information available for 5U19NS120384-02
History
No Historical information available for 5U19NS120384-02
Similar Projects
No Similar Projects information available for 5U19NS120384-02